Shareholders meeting

Date: 29th August, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers 5th Floor, Exchange Plaza, Dalal Street Bandra Kurla Complex, Bandra (East) Mumbai – 400001 Mumbai-400051 Scrip Code: 540937 Symbol: MEDICO Dear Sir/Madam, Sub: Submission of Annual Report for the Financial Year 2025-26 along with the Notice of the 32nd Annual General Meeting Pursuant to Regulation 34 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, we hereby submit the Annual Report for the financial year 2025-26 along with the Notice of the 32nd Annual General Meeting (“AGM”) of the Company. Kindly take the above on record. Yours faithfully For MEDICO REMEDIES LIMITED HARESH MEHTA CHAIRMAN & WHOLE-TIME DIRECTOR DIN: 01080289 Encl: as Above MEDICO REMEDIES LIMITED ANNUAL REPORT 2025-2026 INDEX Sr. No. Particulars Page No. 1 Notice of AGM 1 2 Directors’ Report and its annexures 22 3 Report on Corporate Governance 50 4 Management Discussion and Analysis Report 70 5 Independent Auditor’s Report 74 6 Financial Statements 86 BOARD OF DIRECTORS Mr. Haresh Kapurlal Mehta Chairman and Whole-Time Director Mr. Harshit Haresh Mehta Managing Director Mr. Rishit Haresh Mehta Whole-Time Director Mrs. Rita Haresh Mehta Woman Non-Executive Director Mr. Maheshkumar Darji Executive Director Mr. Deepak Maganlal Vekaria Non-Executive Independent Director Mr. Bharat Nathalal Rathod Non-Executive Independent Director Mr. Deepesh Rajesh Shah Non-Executive Independent Director Mr. Kunal Tushar Vora Non-Executive Independent Director Mr. Anuj Kishore Mody Non-Executive Independent Director COMPANY SECRETARY CHIEF FINANCIAL OFFICER Mr. Hasan Bohra@ Mr. Haresh Kapurlal Mehta Ms. Vidhi Shah# @Resigned w.e.f. 8th August 2025 #Appointed w.e.f. 18th February 2026 STAUTORY AUDITORS INTERNAL AUDITORS Soni Shah and Associates LLP Shah Shroff & Associates Chartered Accountants Chartered Accountants 1112, 11th Floor, Solaris One, A - 703, Winsway Complex, N.S. Phadke Marg, Old Police Lane, Andheri (East), Opp. Teli Gali, Andheri (West), Mumbai 400069 Mumbai - 400069 REGISTRAR & SHARE TRANSFER AGENT Cameo Corporate Services Limited Corp Office: 304 Sai Sadan 3rd Floor 76 - 78, Mody Street, Fort, Mumbai – 400001 REGISTERED OFFICE 1105/1106, 11th Floor, Hubtown Solaris Opp. Telli Galli, N S Phadke Marg, Andheri East, Mumbai - 400069 PLANT LOCATION Plot no. 7, 8 & 9, Dewan & Sons, Udyog Nagar, Lokmanya Nagar, Palghar West-401404 MEDICO REMEDIES LIMITED Notice is hereby given that the Thirty Second Annual General Meeting of the Members of Medico Remedies Limited will be held on Tuesday, 22nd September, 2026 at 4.00 p.m. through Video Conferencing (“VC”) / Other Audio Visual Means (“OAVM”) to transact the following business: ORDINARY BUSINESS: Item No. 1 - ADOPTION OF FINANCIAL STATEMENTS To consider and adopt the Audited Financial Statements for the Financial Year ended 31st March, 2026, together with the Report of the Board of Directors and the Auditors thereon. Item No. 2 - APPOINTMENT OF DIRECTOR To appoint a Director in place of Mr. Haresh Kapurlal Mehta (DIN: 01080289) who retires by rotation and being eligible, offers himself for re-appointment. SPECIAL BUSINESS: Item No. 3: RE-APPOINTMENT OF MR. RISHIT MEHTA (DIN: 07121224) AS WHOLE- TIME DIRECTOR OF THE COMPANY. To consider and if thought fit, pass the following resolution as a Special Resolution: “RESOLVED THAT pursuant to the provisions of Sections 196, 197 and other applicable provisions, if any, of the Companies Act, 2013 (“Act”), read with Schedule V to the Act and the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, and the applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), including any statutory modification(s), amendment(s) or re-enactment(s) thereof for the time being in force, and based on the recommendation of the Nomination and Remuneration Committee and approval of the Board of Directors of the Company, the consent of the Members of the Company be and is hereby accorded for the re-appointment of Mr. Rishit Mehta (DIN: 07121224) as Whole-Time Director of the Company for a further period of 3 (three) years with effect from 18th September, 2026 up to 18th September, 2029, whose office shall be liable to retirement by rotation, on the terms and conditions including remuneration as set out below. RESOLVED FURTHER THAT Mr. Rishit Mehta shall be entitled to the following remuneration and benefits during his tenure as Whole-Time Director: a) Basic Salary Not exceeding ₹7,50,000/- (Rupees Seven Lakh Fifty Thousand only) per month. b) Benefits, Perquisites and Allowances: In addition to the basic salary stated above, Mr. Rishit Mehta shall be entitled to perquisites and allowances as follows: i. Contribution to Provident Fund, Superannuation Fund or Annuity Fund to the extent that these, either singly or put together, are not taxable under the Income-tax Act, 1961; ii. Gratuity benefits in accordance with the rules and regulations of the Company in force from time to time; MEDICO REMEDIES LIMITED iii. Earned/Privilege Leave, Sick Leave and Casual Leave in accordance with the policies of the Company, including leave encashment as per the applicable policy; iv. Such other perquisites, allowances, benefits and amenities as may be provided in accordance with the policies/rules of the Company in force from time to time and/or as may be approved by the Board. The said perquisites and allowances shall be evaluated, wherever applicable, as per the provisions of the Income-tax Act, 1961 or any rules thereunder or any statutory modification(s) or re- enactment(s) thereof and, in the absence of any such rules, at actual cost. c) Bonus: 9% of the Annual Remuneration payable d) Reimbursement of Expenses: Reimbursement of expenses incurred for travelling, boarding and lodging, including those incurred for the spouse and attendant(s) during business trips, medical assistance provided to him and his family members, provision of car(s) for use on the Company's business and telephone expenses at residence, at actuals. Such reimbursement shall not be considered as perquisites. e) Minimum Remuneration: Notwithstanding anything contained herein, where in any financial year during the currency of Mr. Rishit Mehta’s tenure, the Company has no profits or its profits are inadequate, the Company shall pay him the aforesaid remuneration by way of salary, perquisites, allowances and other benefits as minimum remuneration, subject to the applicable provisions and limits prescribed under Schedule V to the Act and such other approvals as may be required. RESOLVED FURTHER THAT the Board of Directors of the Company, including any Committee thereof, be and is hereby authorised to alter and/or vary the terms and conditions of the said re-appointment and/or enhance, enlarge, alter or vary the scope and quantum of remuneration, perquisites, benefits and allowances payable to Mr. Rishit Mehta, within the overall limits approved by the Members and in accordance with the applicable provisions of the Act, Schedule V thereto, the Rules made thereunder and the SEBI Listing Regulations. Item No. 4: RE-APPOINTMENT OF MR. HARESH MEHTA (DIN: 01080289) AS CHAIRMAN & WHOLE-TIME DIRECTOR OF THE COMPANY To consider and if thought fit, pass the following resolution as a Special Resolution: “RESOLVED THAT pursuant to the provisions of Sections 196, 197, 198 and other applicable provisions, if any, of the Companies Act, 2013 (“Act”), read with Schedule V to the Act and the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, and the applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), including any statutory modification(s), amendment(s) or re-enactment(s) thereof for th [Showing first 8,000 characters — download PDF for full document]